Safety of the iDose TR eye implant placed in a doctor's office for glaucoma
Observes how safely iDose TR is placed in adults with glaucoma or high eye pressure.
Plain-language title generated from the registry record
Registry title: iDose TR Administration in an Office-Based Surgery Setting
Key facts
- Where
- Austin, United StatesSee the site
Where in United States
- AustinAustin, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Glaukos Corporation
- Trial code
- NCT07816692
- Record updated
- 30 September 2026
- Original description
Clinical in-use observational trial to evaluate the administration of iDose TR (travoprost intracameral implant) in an office-based surgery setting.Read full original descriptionShow less
Real-World Evidence Observational Study to Evaluate the Safety of iDose® TR (Travoprost Intracameral Implant) 75 µg in an Office-Based Surgery Setting
Clinical in-use observational trial to evaluate the administration of iDose TR (travoprost intracameral implant) in an office-based surgery setting.
Inclusion: Diagnosis of Open angle glaucoma (OAG) or ocular hypertension (OHT).
Exclusion: Prior administration of iDose TR or administration of an investigational intracameral implant in the study eye; Recent ocular surgery; Active ocular infection or inflammation; History of hypersensitivity to travoprost or implant components; Uncontrolled systemic disease; Any condition preventing safe implantation.